Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative

American Journal of Drug and Alcohol Abuse

Volumn 33, Issue 4, 2007, Pages 517-525

  Stein, Michael D ^a,b   Dubyak, Pamela ^a   Herman, Deb ^a,b   Anderson, Bradley J ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Health beliefs; Hepatitis C; HIV risk; Injection drug use

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; EMOTIONAL STRESS; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEEDLE; SELF INJECTION; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION; WITHDRAWAL SYNDROME;

ADULT; ATTITUDE TO HEALTH; FEMALE; HEALTH EDUCATION; HEALTH STATUS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; NEEDLE SHARING; PROBABILITY; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SEROLOGIC TESTS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547572997     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990701407298     Document Type: Article

References (16)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. NEJM 1999; 341:4556-4562.
2. Center for Disease Control and Prevention, 2002. Accessed on July 20, 2006 http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.pdf.
3. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiology 2002; 155:645-653.
4. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Pub Health 1996; 86:655-661.
5. Evans M, Stotts AL, Graham S, Schmitz J, Grabowski J. Hepatitis C knowledge assessment and counseling within the context of substance abuse treatment. Addict Disord Treat 2004; 3:18-26.
6. Janz NK, Becker MN. The health belief model and preventive health behavior. Health Edu Qtrly 1984; 11:1-47.
7. Gibson D, Choi K, Catania J, Sorensen J, Kegeles S. Psychosocial predictors of needle sharing among intravenous drug users. Int J Addict 1993; 28:973-981.
8. Ross MW, Wodak A, Stowe A, Gold J. Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction 1994; 89:473-479.
9. Navaline HA, Snider EC, Petro CJ, Tobin D, Metzger D, Alterman AI, Woody GE. Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): Enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses 1994; 10(Suppl 2):S281-283.
10. Long JS. Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, CA: Sage, 1993.
11. Craine N, Walker M, Carnwath T, Klee H. Hepatitis c testing and injecting risk behaviour: The results of a UK based pilot study. Int J Drug Policy 2004; 15:115-122.
12. Wright NMJ, Tompkins CNE, Jones L. Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. Health Soc Care Comm 2005; 13:75-83.
13. Davis M, Rhodes T, Martin A. Preventing hepatitis c: 'Common sense,' 'the bug' and other perspectives from the risk narratives of people who inject drugs. Soc Sci Med 2004; 59:1807-1818.
14. Lovell AM. Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Soc Sci Med 2002; 55:803-821.
15. Hagan H, Thiede H, Des Jarlais D. Hepatitis C virus infection among injection drug users - Survival analysis of time to seroconversion. Epidemiology 2004; 15:543-549.
16. Rhodes R, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction 2004; 99:621-633.